Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists
First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.
Veteran Technology Executive Joins Synthace to Accelerate Its Mission to Revolutionize the Life Science Research Market
Synthace hires Guy Levy-Yurista as Chief Executive Officer.
Synthace More than Doubles Its Annual Recurring Revenue; Expands Customer Footprint with the Top Pharma Companies in 2020
Strong financial performance and achievement of other key milestones demonstrate the growing strength of Synthace’s offering within biopharma/biotech.
Synthace Appoints Dr. Nick Jurascheck as VP of Engineering
Dr. Jurascheck brings with him more than twenty years of experience spanning senior technology roles in high-tech product companies and consultancies.
Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development through Automation
Two European leaders in biopharma and integrative software are working together to advance drug discovery.
Synthace Rejoins the Pistoia Alliance
Synthace seeks to support the development and adoption of standards and FAIR (findable, accessible, interoperable and reusable) working practices.
New Product to Help Scientists Execute and Scale Key Assays
Scientists using the new ELISA feature in Antha reported 70% reduction in method programming time and 81% reduction in assay design and analysis time.
Clearing the Bioprocess Data Bottleneck in Development of Lentiviral Vectors
An exclusive look into how Synthace’s Antha bioprocess informatics reduces resource demand from data generation to interpretation by 94%.
Computer-Aided Biology: The Metadata Responsibility
Synthace Ltd. is pleased to announce it has released a new comprehensive whitepaper entitled "Computer-Aided Biology: The Metadata Responsibility".